老年肺癌合并慢性阻塞性肺疾病现状及其治疗情况与影响因素分析
CSTR:
作者:
作者单位:

(北京大学人民医院呼吸与危重症医学科,北京100044)

作者简介:

通讯作者:

中图分类号:

基金项目:

北京大学人民医院研究与发展基金(RDJP2024-21)


Analysis of current status and treatment status and influencing factors of lung cancer with chronic obstructive pulmonary disease in the elderly
Author:
Affiliation:

(Department of Respiratory and Critical Care Medicine, Peking University People′s Hospital, Beijing 100044, China)

Fund Project:

This work was supported by the Research and Development Fund of PekingUniversity People's Hospital(RDJP2024-21).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 研究老年肺癌慢性阻塞性肺疾病(LC-COPD)共病和慢性阻塞性肺疾病(COPD)专项治疗现状及相关影响因素。方法 选取2025年1月至5月北京大学人民医院收治的210例老年肺癌(LC)患者作为研究对象,收集患者人口学资料、病情资料、影像学检查结果等数据。所有患者均完成全套肺功能检查,根据患者是否合并COPD将患者分为LC-COPD组与LC组。对LC-COPD患者COPD专项治疗现状进行统计分析,并根据统计结果将LC-COPD组患者进一步分为治疗组和未治疗组。采用SPSS 26.0软件进行数据分析。根据数据类型,组间比较采用独立样本t检验或χ2检验。采用logistic回归模型分析影响老年LC患者LC-COPD共病的相关因素,以及LC-COPD患者是否进行COPD专项治疗的影响因素。结果 210例老年LC患者中,经肺功能检查确诊有128例(60.95%)患者合并COPD。logistic回归分析结果显示,男性(OR=2.102,95%CI 1.278~3.459;P=0.004)、吸烟指数≥400支/年(OR=1.560,95%CI 1.067~2.282;P=0.022)及肺气肿(OR=1.725,95%CI 1.198~2.483;P=0.004)是老年LC-COPD共病的危险因素。128例LC-COPD组患者中,有44例患者进行了COPD相关治疗,其中22例患者依照慢性阻塞性肺疾病全球倡议(GOLD)首选推荐用药方案进行治疗,剩余22例患者未按照指南推荐方案用药。以LC-COPD患者是否进行COPD治疗作为因变量,logistic回归分析结果显示,GOLD分级3~4级(OR=2.168,95%CI 1.160~4.052;P=0.016)、呼吸困难指数评分≥2分(OR=1.738,95%CI 1.234~2.450;P=0.002)、COPD评估测试评分≥10分(OR=1.972,95%CI 1.199~3.244;P=0.008)、体力状况评分≥2分(OR=1.404,95%CI 1.060~1.858;P=0.018)及焦虑(OR=1.335,95%CI 1.091~1.634;P=0.005)是LC-COPD患者进行COPD专项治疗的影响因素。结论 老年LC患者COPD共病率高,应注重男性、吸烟指数≥400支/年、出现肺气肿的老年LC患者的肺功能评估;同时,LC-COPD共病者COPD专项治疗率低,且存在相当比例的用药不规范问题,COPD病情严重、体力状况差以及合并焦虑者更易得到COPD专项治疗,建议临床积极进行COPD病情评估,给予LC-COPD共病患者相应的COPD用药干预。

    Abstract:

    Objective To investigate the current status and related influencing factors of chronic obstructive pulmonary disease (COPD) specific treatment in elderly patients with lung cancer (LC) and COPD (LC-COPD) comorbidity. Methods A total of 210 elderly LC patients admitted to Peking University People′s Hospital from January to May 2025 were enrolled. Demographic data, clinical information, and imaging findings were collected. All patients underwent comprehensive pulmonary function tests, and were divided into a LC-COPD group and a LC group based on whether COPD was present. The current status of specialized COPD treatment was analyzed in the LC-COPD patients, and the LC-COPD group was further assigned into a treated subgroup and an untreated subgroup. SPSS 26.0 statistics was used for data analysis. Data comparisons between two groups was conducted using independent samples t test orχ2 test depending on data type. Logistic regression model was employed to analyze influencing factors for LC-COPD comorbidity and for whether receiving specialized COPD treatment among the LC-COPD patients. Results Among the 210 elderly LC patients, pulmonary function tests confirmed that 128 patients (60.95%) also had COPD. Logistic regression analysis revealed that male (OR=2.102,95%CI 1.278-3.459; P=0.004), smoking index ≥400 cigarettes/year (OR=1.560,95%CI 1.067-2.282; P=0.022) and emphysema (OR=1.725,95%CI 1.198-2.483; P=0.004) were risk factors for LC-COPD comorbidity in elderly LC patients. Of the 128 patients with LC-COPD, 44 patients received COPD-related treatment, including 22 patients who followed the preferred treatment regimens recommended by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), while the remaining 22 patients did not adhere to the guideline recommendations. With whether LC-COPD patients received COPD treatment as the dependent variable, logistic regression analysis revealed that GOLD stage 3-4 (OR=2.168,95%CI 1.160-4.052; P=0.016), dyspnea index score ≥2 points (OR=1.738,95%CI 1.234-2.450; P=0.002), COPD assessment test score ≥10 points (OR=1.972,95%CI 1.199-3.244; P=0.008), physical status score ≥2 points (OR=1.404,95%CI 1.060-1.858; P=0.018) and anxiety (OR=1.335,95%CI 1.091-1.634; P=0.005) were influencing factors for receiving specialized COPD treatment in LC-COPD patients. Conclusion Elderly LC patients exhibit high comorbidity rate of COPD. Lung function assessment should be particularly emphasized among male patients, those with a smoking index ≥400 cigarettes/year and those with emphysema. Additionally, the rate of specialized COPD treatment is quite low among patients with LC-COPD comorbidity, and there are considerable instances of non-adherence to prescribed therapies. Patients with severe COPD, poor physical condition, or comorbid anxiety are more likely to receive targeted COPD treatment. It is recommended that clinicians should conduct comprehensive COPD assessments and provide appropriate pharmacological interventions for patients with LC-COPD comorbidity.

    参考文献
    相似文献
    引证文献
引用本文

梁新培,李蕊,喻言,杨艟舸,高占成.老年肺癌合并慢性阻塞性肺疾病现状及其治疗情况与影响因素分析[J].中华老年多器官疾病杂志,2026,25(7):493-498
DOI:10.11915/j. issn.1671-5403.2026.07.101

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-07-19
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-08-05
  • 出版日期:
文章二维码